T. Modric et al., Pregnancy-dependent expression of leukaemia inhibitory factor (LIF), LIF receptor-beta and interleukin-6 (IL-6) messenger ribonucleic acids in the porcine female reproductive tract, PLACENTA, 21(4), 2000, pp. 345-353
Leukaemia inhibitory factor (LIF) and interleukin-6 (IL-6) are candidate em
bryo-maternal signalling molecules which are present within the uterine lum
inal micro-environment. We examined the relative expression of the mRNAs en
coding LIF and IL-6, as well as the LIF-binding subunit (LIFR-beta) of the
LIF receptor and, as a potential downstream cytokine-responsive gene, beta(
2)-microglobulin (beta(2)m), in porcine peri-implantation conceptuses, and
in placenta and endometrium during early and mid-pregnancy. Peri-implantati
on spherical and filamentous conceptuses expressed LIFR-beta and beta(2)m m
RNAs with no LIF mRNA present. Rapid development in days 11/12 spherical co
nceptuses to the filamentous stage was accompanied by transiently increased
IL-6 gene expression. The corresponding endometrium, in contrast, expresse
d LIF in addition to these other mRNAs. LIFR-beta, IL-6 and beta(2)m, but n
ot LIF mRNAs, were expressed in the Jag-1 cell line, an in vitro model for
porcine day 14 trophoblast. The greatest steady-state amounts of LIF, LIFR-
beta and IL-6 mRNAs in both the endometrium and placenta were evident at th
e post-implantation stages (days 30 and 60>day 18 of pregnancy). Treatment
of porcine endometrial explants with human recombinant (hr)LIF or hrIL-6 re
sulted in no change in, or diminished, the presence of endometrial beta(2)m
mRNA, respectively. Addition of LIF to peri-implantation conceptus explant
cultures, in contrast, induced beta(2)m mRNA synthesis. These results high
light the potential importance of both the endometrium and placenta as sour
ces, as well as targets, of these cytokines throughout pregnancy. Cytokine
modulation of beta(2)m, a known in vitro mitogen, may constitute one mechan
ism for local control of trophoblast and endometrial proliferation. (C) 200
0 Harcourt Publishers Ltd.